Reliv's Dr. Carl Hastings is rated #9 out of 5000

Out of more than 5000 Chief Scientific Officers in the United States, Reliv's Dr. Carl Hastings is rated #9.  

Reliv’s Dr. Carl Hastings Named Top 10 Chief Scientific Officer
ExecRank lists Hastings ninth among more than 5,000 CSOs in the United States

CHESTERFIELD, MO, April 3, 2013 – Reliv International (NASDAQ: RELV) today announced that ExecRank executive ranking service has named Reliv’s Dr. Carl Hastings number nine on their Top Chief Scientific Officers Ranking list for 2012. Hastings joins a top ten of the nation’s leading CSOs, many of them from Fortune 100 companies. According to ExecRank, there are over 5,000 Chief Scientific Officers and C-Level Scientific Executives in the United States and this list represents “the best of the best in their field.”“This honor is hard-earned and well-deserved,” said Robert L. Montgomery, Reliv Chairman and CEO. “Carl is a man of science who has devoted his life to developing breakthrough nutritional solutions to help meet the world’s biggest health needs. The top ten ranking only confirms what his peers and we at Reliv have known for years: Dr. Carl Hastings is one of the leading nutrition scientists in the world.” 

A Very Good Year   The ExecRank listing comes following a year in which Hastings earned two product patents (his sixth and seventh) and introduced LunaRich® soy powder and LunaRich X™. LunaRich products optimize bioactive lunasin, the soy peptide research shows works at the epigenetic level to promote cellular health.GlucAffect®, Reliv’s blood sugar management formula, earned a patent in February 2012 and ProVantage®, Reliv’s athletic performance enhancement product, followed with its own patent in May. Both products now contain LunaRich, a Reliv-exclusive ingredient that delivers more bioactive lunasin — many times more — than any other soy powder available today.